Ann: Notices received under S203D and S249D of Corporations Act, page-69

First 69 Last

Share
Profile

Follow
itsagas

14,671 Posts.

1584

27/02/25

15:43

Post #: 78058440
Share

Originally posted by Motors: ↑

There is currently no business plan . So why would there be any insto interest, instos can't buy unless a clear plan to sell to their investment committees. All you have is a bunch of High Net worths (including Garner) happy to buy below cash backing, but absolutely no higher . PVL is after the cash , don't be under any other illusion, they probably want to grow their funds management business, but are very low on cash to do that, you need money if you want to invest in listed ideas!

Garner's average entry price is 1.2 cents, PVL's average entry price is 1 cent . And as far as I can tell Gennadi hasn't bought any meaningful stock since the battle for control began. Really that tells you all you need to know . Gennadi etc are promising big things if they get their hands on the vehicle, but have yet not bought anything on market, that makes next weeks vote an easy one for me

And then personally ,rightly or wrongly , as far as I'm concerned Moses/Gennadi/Diamond and the phase 1 trial are where the issue is. Garner just tried to monetise 20 years of rubbish science during the pump and dump that was COVID, without blowing up the company. I'm not going back to the pain of 2002-2019, and the world of cut paste investor presos and relentless capital raisings of Gennadi/Diamond.. .

Expand

Voting closed
Results 4/ March Tuesday
Meeting online…
Let’s get this nonsense over with…
So Per can get back on track for the sake of genuine shareholders…

PER Price at posting: 1.3¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 69 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.1¢		Change 0.001(5.00%)		Mkt cap ! $11.41M

Open	High	Low	Value	Volume
1.2¢	1.3¢	1.0¢	$247.0K	21.17M

Buyers (Bids)

No.	Vol.	Price($)
3	480000	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	201000	2

View Market Depth

No.	Vol.	Price($)
2	380000	0.011
11	4723802	0.010
8	6438144	0.009
3	975000	0.008
3	1585000	0.007

Price($)	Vol.	No.
0.007	201000	2
0.008	95818	1
0.009	262800	1
0.010	175000	2
0.011	1066000	4

Last trade - 15.31pm 26/06/2025 (20 minute delay)

PER (ASX) Chart

Ann: Notices received under S203D and S249D of Corporations Act, page-69

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Notices received under S203D and S249D of Corporations Act, page-69

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News